Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-494-5 | CAS number: 96-26-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2007-03-19 - 2007-07-18
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted 24 April 2002
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 1,3-dihydroxyacetone
- EC Number:
- 202-494-5
- EC Name:
- 1,3-dihydroxyacetone
- Cas Number:
- 96-26-4
- Molecular formula:
- C3H6O3
- IUPAC Name:
- 1,3-dihydroxyacetone
- Details on test material:
- Purity: 100.3 %
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Netherlands
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 7-12 weeks
- Weight at study initiation: 19.5 +/- 1.8 g
- Housing: single (Makrolon Type I, with wire mesh top)
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 1 week
- Indication of any skin lesions: no
ENVIRONMENTAL CONDITIONS
- Temperature: 22 +/- 3°C
- Humidity: 30-70%
- Photoperiod: 12 hrs dark / 12 hrs light
- IN-LIFE DATES: From: 2007-03-21 To: 2007-03-27
Study design: in vivo (LLNA)
- Vehicle:
- other: Ethanol/water (30/70, v/v)
- Remarks:
- The vehicle was selected based on pretests: Ethanol/water (30/70, v/v) resulted in the the highest test item concentration which could be achieved technically. This concentration could not be prepared using other vehicles as recommended by OECD TG 429.
- Concentration:
- 12.5, 25, or 50 %
- No. of animals per dose:
- 5
- Details on study design:
- PRE-SCREEN TESTS:
- Compound solubility: up to 50% in Ethanol/water (30/70, v/v)
- Concentrations tested in the pretest: 6.25, 12.5, 25 and 50%
- Irritation: no signs of irritation
- Systemic toxicity: no systemic toxicity
- Ear thickness measurements: no relevant increased ear thickness observed
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay (LLNA)
- Criteria used to consider a positive response: A test item is regarded as a sensitizer in the LLNA if the following criteria are fulfilled:
First, that exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice, as indictaed by the SI (stimulation index)
Second, that the data are compatible with a conventional dose response, although allowance must be made (especially at high concentrations) for either local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION:
The test item was placed into a volumetric flask glass beaker on a tared balance and the vehicle was quantitatively added. The test item concentrations were prepared serially.
Three groups each of 5 mice were treated with 12.5, 25, or 50 % Dihydroxyacetone by topical application at the dorsum of each ear lobe (left and right) on three consecutive days. A control group of 5 mice was treated with the vehicle only. The application volume (25 µL) was spread over the entire dorsal surface of each ear lobe. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated in the body weight tables.
The Dunnett-Test (ANOVA) was conducted to assess whether the difference of DPM per animal is statistically significant between test item groups and negative control (vehicle) group. A statistical analysis of the earthickness before and after treatment with the test item was also conducted.
Results and discussion
- Positive control results:
- The validation-(positive control experiment was performed with a-Hexylcinnamaldehyde in acetone:olive oil (4+1) using CBA/CaOIaHsd mice.
Disintegrations per minute (DPM) of 1005.4, 3108.1, and 6130.7 were determined with the positive control at concentrations of 5, 10, and 25 %, respectively.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 1.04
- Variability:
- 0.5 - 1.3
- Test group / Remarks:
- Low Dose (12.5%)
- Key result
- Parameter:
- SI
- Value:
- 1.16
- Variability:
- 0.7 - 1.4
- Test group / Remarks:
- Mid Dose (25%)
- Key result
- Parameter:
- SI
- Value:
- 0.77
- Variability:
- 0.3 - 1.3
- Test group / Remarks:
- High Dose (50%)
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
see table
EC3 CALCULATION
All SI values were < 3, i.e. EC3 values could not be calculated.
CLINICAL OBSERVATIONS
No symptoms of local toxicity at the ears of the animals and no systemic findings were observed during the study period.
BODY WEIGHTS
The body weight of the animals, recorded prior to the first application and prior to treatment with 3HTdR was within the range commonly recorded for animals of this strain and age.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test item is not a skin sensitiser based on the results of this study.
- Executive summary:
In order to study a possible skin sensitizing potential of the test material, three groups of five female mice each were treated daily with the test item at concentrations of 12.5%, 25% and 50% (w/v) in ethanol/water (30/70 v/v) by topical application to the dorsum of each ear lobe for three consecutive days. A control group of five female mice was treated with the vehicle only. The vehicle ethanol/water (30/70 v/v) was selected based on results of a pretest as it enables the highest concentration of the dissolved test item.
Five days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (3H-methyl thymidine, 3HTdR). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes were excised and pooled per animal (2 nodes per animal). Single cell suspensions of pooled lymph node cells were prepared, which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3HTdR measured in a β-scintillation counter.
All treated animals survived the scheduled study period. Neither clinical signs on the ears of the animals nor systemic findings were observed during the study period. The development of the body weight was inconspicuous.
The results obtained [Stimulation Index (S.I.)] are summarized in the following table.
Test item concentration SI value 12.5% 1.04 25.0% 1.16
50.0% 0.77 All SI values were </= 3, i.e. the test was negative with regard to a skin sensitizing potential.
Based on the results of this study, the test material is considered to be not a skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
